Bigfoot Biomedical Announces Late-Breaking Poster Presentation and Product Theater at the 2022 American Diabetes Association 82nd Scientific Sessions
yahoo.com
news
2022-06-01 12:00:00

MILPITAS, Calif., June 01, 2022--(BUSINESS WIRE)--Bigfoot Biomedical, a mission-driven company dedicated to supporting better health outcomes for people with insulin-requiring diabetes, today announced late-breaking presentation of "The First Real World Experience with Bigfoot Unity: A 3-Month Retrospective Analysis" at the 2022 American Diabetes Association (ADA) 82nd Scientific Sessions. The company will also host a product theater at the event focused on the shift from traditional clinical care to remote physiologic monitoring and management of people on multiple daily injections (MDI) of insulin.
